年表作成・共有サービス - pastport

http://beilupharma.com/products/iodixanol-injection.html

Contrast Media
Beilu Pharma offers an extensive range of Contrast Media products for Diagnostic Imaging to help healthcare professionals to make decisive solution through technical imaging data. It concentrates on innovation and quality, constantly upgrading, and aims to be one of the world's most admired brands.

MRI Contrast Media
Gadopentetate Dimeglumine Injection/API
Gadobutrol Injection/API
Gadobenate Dimeglumine Injection
Ferric Ammonium Citrate Effervescent Granules

CT/X-Ray Contrast Media
Iohexol Injection
Iopamidol Injection
Iodixanol Injection

Anti-Diabetic Drugs
The number of people with diabetes rose from 151 million in 2000 to 463 million in 2019; by 2045 this number will rise to 700 million. 1 in 5 of the people who are above 65 years old have diabetes, 1 in 2 people (232 million) with diabetes were undiagnosed, and diabetes caused 4.2 million deaths. Diabetes caused at least USD760 billion dollars in health expenditure in 2019 – 10% of total spending on adults. More than 1.1 million children and adolescents are living with type 1 diabetes, and 374 million people are at increased risk of developing type 2 diabetes.

Diabetes is a chronic disease. Diabetes occurs when the pancreas cannot produce enough insulin or the body cannot effectively use the produced insulin (diabetes is a hormone that regulates blood sugar). High blood sugar or elevated blood sugar is a common result of uncontrolled diabetes. Over time, diabetes can seriously damage many systems of the human body, especially nerves and blood vessels, so the prevention and treatment of diabetes is particularly important in our daily life. In fact, the incidence of diabetes in low- and middle-income countries is rising faster than in high-income countries. As the health problems of diabetes threaten people's lives seriously, the prevention of diabetes and the corresponding antidiabetic medications have also attracted more and more attention. As a professional anti-insulin drugs manufacturer, Beilu Pharma can provide you with 2 different types of high-quality oral antidiabetic drugs.

Anti-Anxiety Drug
How to identify patients with anxiety?
Chief complaints:

Typical somatic symptoms: fatigue, weakness, insomnia, thought slowness, poor appetite

Somatic symptoms A: palpitation, oppression in chest, chest pain, dyspnea, profuse sweating

Somatic symptoms B: headache, dizziness

Somatic symptoms C: abdominal pain, abdominal distension, diarrhea, nausea, dysphagia, weight loss

Somatic symptoms D: dry mouth, constipation, frequent urination, urgent urination, skin flushing or paleness

API

Intermediates

Excipients

Why Choose Beilu
Beilu Pharma is a leader and pioneer in the Contrast Media field in China. It provides a wide range of Contrast Media products for diagnostic imaging and interventional therapy, and it also offers Anti-diabetic and Anti-anxiety medicines to improve the treatment and help healthcare professionals solve problems.

The success of developing and marketing Contrast Media in the local market promotes us to explore overseas market and Beilu Pharma has currently expanded its footprints across Southeast Asia, Africa, Latin America, and Middle East markets. In 2020, Beilu Pharma successfully completed the acquisition of one of the largest Contrast Media API manufacturers-Zhejiang Hichi Pharmaceutical Co., Ltd. and upgraded the strategic layout of industrial chain integration.

Beilu Pharma is open to collaborating with any interested and relevant parties worldwide and we will continue to strive to provide high-quality products at a competitive price.

Beilu is a professional contrast media manufacturer, we provide visipaque contrast media, iodixanol visipaque, visipaque 320 and etc. Want to know more?contact us now.